A detailed history of Manufacturers Life Insurance Company, The transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 50,996 shares of CORT stock, worth $2.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,996
Previous 48,780 4.54%
Holding current value
$2.94 Million
Previous $1.58 Million 48.93%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$29.51 - $46.26 $65,394 - $102,512
2,216 Added 4.54%
50,996 $2.36 Million
Q2 2024

Aug 14, 2024

BUY
$22.21 - $34.48 $20,699 - $32,135
932 Added 1.95%
48,780 $1.58 Million
Q1 2024

May 14, 2024

BUY
$21.1 - $27.46 $110,564 - $143,890
5,240 Added 12.3%
47,848 $1.21 Million
Q4 2023

Feb 13, 2024

SELL
$24.82 - $32.88 $17,448 - $23,114
-703 Reduced 1.62%
42,608 $1.38 Million
Q3 2023

Nov 15, 2023

BUY
$21.97 - $33.8 $221,303 - $340,467
10,073 Added 30.31%
43,311 $1.18 Million
Q2 2023

Aug 11, 2023

SELL
$21.44 - $25.15 $35,783 - $41,975
-1,669 Reduced 4.78%
33,238 $739,000
Q1 2023

May 15, 2023

BUY
$19.2 - $24.47 $1,401 - $1,786
73 Added 0.21%
34,980 $757,000
Q4 2022

Aug 11, 2023

BUY
$19.95 - $29.96 $7,042 - $10,575
353 Added 1.02%
34,907 $708,000
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $7,042 - $10,575
353 Added 1.02%
34,907 $708,000
Q3 2022

Aug 11, 2023

SELL
$24.7 - $29.12 $13,659 - $16,103
-553 Reduced 1.58%
34,554 $885,000
Q3 2022

Nov 03, 2022

SELL
$24.7 - $29.12 $13,659 - $16,103
-553 Reduced 1.58%
34,554 $886,000
Q2 2022

Aug 11, 2023

SELL
$17.33 - $25.3 $30,968 - $45,211
-1,787 Reduced 4.84%
35,107 $834,000
Q2 2022

Aug 15, 2022

SELL
$17.33 - $25.3 $30,968 - $45,211
-1,787 Reduced 4.84%
35,107 $835,000
Q1 2022

Aug 11, 2023

BUY
$16.53 - $25.21 $31,638 - $48,251
1,914 Added 5.47%
36,894 $830,000
Q1 2022

May 20, 2022

SELL
$16.53 - $25.21 $202,542 - $308,898
-12,253 Reduced 24.93%
36,894 $831,000
Q4 2021

Feb 16, 2022

SELL
$17.1 - $23.34 $15,732 - $21,472
-920 Reduced 1.84%
49,147 $973,000
Q3 2021

Nov 12, 2021

SELL
$19.68 - $22.53 $99,639 - $114,069
-5,063 Reduced 9.18%
50,067 $985,000
Q2 2021

Aug 12, 2021

SELL
$19.97 - $24.43 $599 - $732
-30 Reduced 0.05%
55,130 $1.21 Million
Q1 2021

May 03, 2021

SELL
$23.49 - $30.56 $77,563 - $100,909
-3,302 Reduced 5.65%
55,160 $1.31 Million
Q4 2020

Feb 12, 2021

BUY
$16.78 - $27.3 $41,379 - $67,321
2,466 Added 4.4%
58,462 $1.53 Million
Q3 2020

Nov 09, 2020

SELL
$12.46 - $19.98 $20,870 - $33,466
-1,675 Reduced 2.9%
55,996 $975,000
Q2 2020

Aug 10, 2020

SELL
$11.0 - $18.26 $38,929 - $64,622
-3,539 Reduced 5.78%
57,671 $966,000
Q1 2020

May 15, 2020

BUY
$10.11 - $14.04 $33,888 - $47,062
3,352 Added 5.79%
61,210 $728,000
Q4 2019

Feb 14, 2020

SELL
$12.06 - $16.96 $2.87 Million - $4.04 Million
-238,019 Reduced 80.45%
57,858 $700,000
Q3 2019

Nov 12, 2019

BUY
$10.41 - $14.66 $2.44 Million - $3.43 Million
234,219 Added 379.87%
295,877 $4.31 Million
Q2 2019

Aug 14, 2019

SELL
$9.78 - $12.76 $2.76 Million - $3.6 Million
-282,494 Reduced 82.08%
61,658 $687,000
Q1 2019

May 13, 2019

BUY
$10.03 - $15.71 $3,149 - $4,932
314 Added 0.09%
344,152 $4.04 Million
Q4 2018

Feb 14, 2019

SELL
$11.29 - $17.19 $499,876 - $761,104
-44,276 Reduced 11.41%
343,838 $4.59 Million
Q3 2018

Nov 14, 2018

BUY
$12.27 - $15.65 $639,058 - $815,098
52,083 Added 15.5%
388,114 $5.44 Million
Q2 2018

Aug 14, 2018

BUY
$15.3 - $19.69 $689,112 - $886,837
45,040 Added 15.48%
336,031 $5.28 Million
Q1 2018

May 15, 2018

BUY
$14.59 - $25.5 $791,697 - $1.38 Million
54,263 Added 22.92%
290,991 $4.79 Million
Q4 2017

Feb 08, 2018

BUY
$15.77 - $20.72 $895,010 - $1.18 Million
56,754 Added 31.53%
236,728 $4.28 Million
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $2.21 Million - $3.47 Million
179,974
179,974 $3.47 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.18B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.